12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Repare Therapeutics RPTX shares rose 34.1% to $4.4 during Wednesday's pre-market session. The company's market cap stands at $186.7 million. The company's, Q1 earnings came out yesterday.
• Enveric Biosciences ENVB shares increased by 16.85% to $1.04. The company's market cap stands at $7.5 million.
• Clover Health Investments CLOV stock increased by 16.21% to $0.86. The company's market cap stands at $426.3 million. As per the press release, Q1 earnings came out yesterday.
• Envoy Medical COCH stock rose 13.88% to $3.28. The company's market cap stands at $64.2 million.
• Myriad Genetics MYGN stock moved upwards by 13.75% to $22.5. The market value of their outstanding shares is at $2.0 billion. As per the press release, Q1 earnings came out yesterday.
• CEL-SCI CVM stock increased by 13.1% to $1.89. The market value of their outstanding shares is at $101.9 million.

Losers

• Treace Medical Concepts TMCI shares fell 58.5% to $4.61 during Wednesday's pre-market session. The market value of their outstanding shares is at $285.5 million. As per the news, the Q1 earnings report came out yesterday.
• Inspire Medical Systems INSP shares fell 16.85% to $204.25. The market value of their outstanding shares is at $6.1 billion. As per the press release, Q1 earnings came out yesterday.
• Immuron IMRN shares fell 13.15% to $2.18. The market value of their outstanding shares is at $12.4 million.
• Semler Scientific SMLR stock decreased by 12.69% to $24.58. The market value of their outstanding shares is at $172.8 million. As per the news, the Q1 earnings report came out yesterday.
• Nuwellis NUWE stock decreased by 9.91% to $0.24. The company's market cap stands at $3.6 million. The company's, Q1 earnings came out yesterday.
• OPKO Health OPK shares decreased by 9.24% to $1.18. The market value of their outstanding shares is at $822.4 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.